Mutations in the calcium-sensing receptor and their clinical implications

Hormone Research in Paediatrics

Volumn 48, Issue 5, 1997, Pages 199-208

  Brown, Edward M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autosomal dominant hypocalcemia; Calcium homeostasis; Extracellular calcium sensing receptor; Familial hypocalciuric hypercalcemia; Kidney; Neonatal severe hyperparathyroidism; Parathyroid

Indexed keywords

CALCIUM; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; CELL RECEPTOR; MAGNESIUM ION; VITAMIN D;

AUTOSOMAL DOMINANT INHERITANCE; BRAIN; CALCIUM HOMEOSTASIS; EXTRACELLULAR CALCIUM; GENE MUTATION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; LARGE INTESTINE; LUNG; NEPHRON; NONHUMAN; PARATHYROID CELL; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE; WATER METABOLISM;

EID: 0030732954     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185516     Document Type: Article

References (49)

1. Chattopadhyay N, Mithal A, Brown E: The calcium receptor: A new handle on the diagnosis and treatment of parathyroid disorders. Endocrine Rev 1996:17:289-307.
2. 2*-scnsing receptor from bovine parathyroid. Nature 1993:366:575-580.
3. Poliak M, Brown E, Chou Y, Hebert S, Marx S, Steinmann B, Levi T, Scidman C, Scidman J: Mutations in the human Ca’-scnsing receptor gene cause familial hvpocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993;75:1297-1303.
4. 2‘-sensing receptor gene mutation. Nat Genet 1994:8:303-307.
5. 2* and other ions as extracellular (first) messengers. Physiol Rev 1991:71:371-411.
6. 2* on renal function? J Am Soc Nephrol 1995:6:1530-1540.
7. Nemeth EF, Wallace J, Scarpa A: Stimulus-secrclion coupling in bovine parathyroid cells. Dissociation between secretion and net changes in cytosolic Ca**. J Biol Chem 1986: 261:2668-2674.
8. Riccardi D, Park J, Lee W, Gamba G, Brown E, Hebert S: Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 1995:92:131-135.
9. 2*-sensing receptor eDNA from human kidney. Biochem Biophys ResCommun 1995:214:524-529.
10. Butters R, Chattopadhyay N, Nielsen P, Smith C, Mithal A, Kifor O, Bai M, Quinn S, Goldsmith P, Hurwitz S, Krapcho K, Busby J, Brown E: Cloning and characterization of a calcium-sensing receptor from the hypercalcemic New Zealand white rabbit reveals unaltered responsiveness to extracellular calcium. J Bone Mineral Res 1997;12:568-579.
11. Garrett JE, Tarnir H, Kifor O, Simin RT, Rogers KV, Mithal A, Gagel RF, Brown EM: Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 1995;136:5202-5211.
12. Ruat M, Molliver M, Snowman A, Snyder S: Calcium sensing receptor: Molccularcloning in rat and localization to nerve terminals. Proc Natl AcadSci USA 1995;92:3161-3165.
13. Garrett J, Capuano I, Hammerland L, Hung B, Brown E, Hebert S, Nemeth E, Fuller F: Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chcm 1995:270:12919-12925.
14. Heath H III, Odclbcrg S, Jackson C, Teh B, Hayward N, Larsson C, Buist N, Krapcho K, Hung B, Capuano I, Garrett J, Lcppert M: Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 1996:81:1312-1317.
15. 2* in bovine parathyroid cells and human embryonic kidney (HEK293) cells. J Bone Mineral Res 1997;12:715-725.
16. 2*-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996;271:C103-C111.
17. Riccardi D, Lee W-S, Lee K, Segrc G, Brown E, Hebert S: Localization of the extracellular Ca*-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 1996;27l: F951-F956.
18. Sands J, Naruse M, Baum M, Hebert S, Brown E, Harris W: An apical extracellular calcium/ polyvalent cations-sensing receptor (C'aR) regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 1997;99:1399-1405.
19. Simpson J, Routenberg A: Inffornical organ lesions reduce intravenous angiotensin-induced drinking. Brain Res 1975:88:154-161.
20. Marx SI, Attic MF, Levine MA, Spiegel AM, Downs RW Jr., Lasker RD: The hypocalciuric or benign variant of familial hypercalcemia: Clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 1981:60:397-412.
21. Chou Y-H, Brown E, Levi T, Crowe G, Atkinson A, Amqvist H, Toss G, Fuleihan G, Scid-man J, Seidman C: The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet 1992:1:295-300.
22. 2+-sensing receptor gene. J Clin Endocrinol Metab 1995;80:2594-2598.
23. 2*-sensing receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet 1995:56:1075-1079.
24. 2-sens-ing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet. 1995;56:880-886.
25. Pearce S, Trump D, Wooding C, Besser G, Chew S, Heath D, Hughes I, Thakkcr R: Calcium-sensing receptor mutations in familial benign hypcrcalcaemia and neonatal hyperparathyroidism. J Clin Invest 1995:96:2683-2692.
26. 2V sensing receptor. J Biol Chem 1996;271: 19537-19545.
27. Pearce S, Bai M, Quinn S, Kifor O, Brown E, Thakkcr R: Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 1996:98:1860-1866.
28. 2-scnsing receptor gene - normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest, in press.
29. Attie M, Gill JJ, Stock J, Spiegel A, Downs RJ, Levine M, Marx S: Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hvpocalciuria after induction of hypoparathyroidism. J Clin Invest 1983;72:667-676.
30. Quamme G: Control of magnesium transport in the thick ascending limb. Am J Physiol 1989; 256:F197-F210.
31. Heath D: Familial hypocalciuric hypercalcemia; in Bilezikian J. Marcus R. Levine M (eds): The Parathyroids. New York. Raven Press, 1994, pp 699-710.
32. Marx S, Attie M, Spiegel A, Levine M, Lasker R, Fox M: An association between neonatal severe primary' hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med 1982;306:257-284.
33. Spiegel A: Mutations in G protein and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 1996:81:2434-2442.
34. Heath H III, Jackson C, Otterud B, Leppert M: Genetic linkage analysis of familial benign (hypocalciuric) hypercalcemia: Evidence for locus heterogeneity. Am J Hum Genet 1993:53:193-200.
35. Trump D, Whyte M, Wooding C, Pang J, Pearce S, Kocher D, Thakker R: Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcacmia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH. Hum Genet 1995:96:183-187.
36. 2’-scnsing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996:5:601-606.
37. 2*-sens-ing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism. Hum Genet 1996:98:129-133.
38. Pearce S, Williamson C, Kifor O, Bai M, Coulthard M, Davies M, Lcwis-Barncd N, McCredic D, Powell H, Kendall-Taylor P, Brown E, Thakkcr R: A familial syndrome of hypocalcemia with hypcrcalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996:335:1115-1122.
39. Ho C, Conner DA, Poliak M, Ladd DJ, Kifor O, Warren H, Brown EM, Seidman CE, Scid-man JG: A mouse model for familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 1995:11:389-394.
40. 2*-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 1995:80: 3107-3110.
41. 2*-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996;1:1598-1606.
42. Brown E, Poliak M, Seidman C, Seidman J, Chou Y-H, Riccardi D, Hebert S: Calcium-ion-sensing cell-surface receptors. N Engl J Med 1995:333:234-240.
43. Marx SJ, Attie MF, Stock JL, Spiegel AM, Levine MA: Maximal urine-concentrating ability: Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab 1981;52:736-740.
44. Cholst I, Steinberg S, Troppcr P, Fox H, Segrc G: The influence of hypermagnesemia on scrum calcium and parathyroid hormone levels in human infjects. N Engl J Med 1984:310: 1221-1225.
45. 2* receptor-dependent regulation of cellular function. News Physiol Sci 1995:10: 1-5.
46. Silvetberg S, Thys-Jacobs S, Locker F, Sangui-nctti E, Marriott T, Bilezikian J: The effects of the calcimimctic drug NPS R-568 on parathyroid hormone secretion in primary hyperparathyroidism (abstract 87). J Bone Miner Res 11 (suppl 1):S116:1996.
47. Hammerland L, Garrett J, Krapcho K, Simin R, Capuano I, Alasti N, Nemeth E: NPS R-467 activation of chimeric calcium-metabotropic glutamate receptor and a calcium receptor deletion mutant indicates a site of act ion within the transmembrane domain of the calcium receptor (abstract P272). J Bone Mineral Res 1996; 11 (suppl 1):S158.
48. Heinemann U, Lux HD, Gutnick MJ: Extracellular free calcium and potassium during paroxysmal activity in cerebral cortex of the rat. Exp Brain Res 1977;27:237-243.
49. Ye C, Ho C, Kanazirska M, Quinn S, Rogers K, Seidman C, Seidman J, Brown E, Vassilev P: Calcium-sensing receptor as a target for the actions of amyloid C1 proteins. J Neurosci Res 1997:47:547-554.